- Recommendation ID
- CG173/3
- Question
- Carbamazepine for treating trigeminal neuralgia:- What is the clinical and cost effectiveness of carbamazepine as initial treatment for trigeminal neuralgia compared with other pharmacological treatments?
- Any explanatory notes
(if applicable) - Why this is important:- Carbamazepine has been the standard treatment for trigeminal neuralgia since the 1960s. Despite the lack of trial evidence, it is perceived by clinicians to be efficacious. Further research should be conducted as described within the guidance.
Source guidance details
- Comes from guidance
- Neuropathic pain in adults: pharmacological management in non-specialist settings
- Number
- CG173
- Date issued
- November 2013
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 19/12/2013 |